Piermont Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-14,400
| Closed | -$177K | – | 252 |
|
|
2017
Q3 | $177K | Sell |
14,400
-15,310
| -52% | -$188K | 0.06% | 241 |
|
|
2017
Q2 | $489K | Sell |
29,710
-5,160
| -15% | -$84.9K | 0.14% | 230 |
|
|
2017
Q1 | $500K | Hold |
34,870
| – | – | 0.12% | 230 |
|
|
2016
Q4 | $482K | Sell |
34,870
-670
| -2% | -$9.26K | 0.11% | 229 |
|
|
2016
Q3 | $642K | Buy |
+35,540
| New | +$642K | 0.15% | 207 |
|